Nuvation Pharma (NUVB): Rasio rega marang pendapatan

Tandha merek Nuvation Corp (NUVB)

Nuvation Bio Inc. (NUVB) focuses on integrating acquired assets and conducting clinical trials while maintaining strict liquidity control. This P/S chart demonstrates the current market valuation, with the latest mark standing at 7.00. Growth potential is based on the market launch of BET inhibitors for solid tumors, while stability is ensured by the diversification of the drug portfolio across various stages of development.

NUVB Multiplikator P/S Nuvation Bio Inc. (06.08.2024 - 13.11.2026)

Nuvation Pharma (NUVB) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Rega bursa nuvationbio.com|NUVB - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar Nuvation Pharma|NUVB - Nilai Total Perusahaan
- statistik nilai buku emiten:
Nilai Aset Bersih saben Saham Nuvation Bio|NUVB - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas nuvationbio.com|NUVB - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Modal Nuvation Bio Inc.|NUVB - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Nuvation Corp|NUVB - Gunggung utang perusahaan|Utang marang modal buku Nuvation Pharma|NUVB - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Nuvation Bio|Likuiditas darurat nuvationbio.com
- data bathi lan kelipatan valuasi:
NUVB - Bathi resik perusahaan|Penghasilan resik sing dikarepake Nuvation Bio Inc.|NUVB - Pangali P/E|Pangali Forward P/E Nuvation Bio Inc|NUVB - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Nuvation Pharma|NUVB - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Nuvation Bio|NUVB - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan nuvationbio.com|NUVB - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Nuvation Bio Inc.
- rincian pendapatan lan dodolan emiten:
NUVB - Dodolan perusahaan|Prakiraan pendapatan perusahaan nuvationbio.com|NUVB - Multiplikator P/S|Multiplikator Forward P/S Nuvation Pharma
Ringkesan analitik perusahaan:nuvationbio.com
Produk seri Nuvation Corp

Against the backdrop of pipeline restructuring and the development of targeted oncology drugs following the acquisition of AnHeart Therapeutics, this price-to-sales valuation reflects the market capitalization of Nuvation Bio Inc. (NUVB) relative to its generated revenue. Analyzing this multiple allows for the determination of fair value sales boundaries, helping investors differentiate fundamental asset growth from speculative volatility during the company's critical innovation cycle.

Perusahaan pesaing

INCY - Rega marang dodolan|Rasio rega marang pendapatan HUTCHMED HCM|Day One Biopharmaceuticals, Inc. - Rasio rega marang pendapatan|MNPR - Rasio rega marang pendapatan|Rega marang dodolan Inhibrx Corp|IMAB: Multiplikator P/S|Multiplikator rega marang pendapatan fennecpharma.com FENC|Kapitalisasi marang pendapatan HRTX|Rega marang dodolan Nuvectis Pharma Inc. NVCT|Kapitalisasi marang pendapatan CHRS (Coherus)|CRBP (Corbus Pharmaceuticals, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Cardiff Oncology - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan BYSI (beyondspringpharma.com)|BioAtla Corp - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan LIXT (Lixte Biotechnology Holdings Inc.)|CTXR: Multiplikator P/S|Rega marang dodolan Cellectar Corp (CLRB)|Rasio rega marang pendapatan BioLineRx Ltd.|CANF: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S APRE|Multiplikator P/S kaziatherapeutics.com (KZIA)|Rasio rega marang pendapatan Silexion Therapeutics SLXN|NCNA (NuCana PLC) - Rasio rega marang dodolan|CMRX: Kapitalisasi marang pendapatan|Rega marang dodolan cyclacel.com|g1therapeutics.com (GTHX) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan KRON|Kapitalisasi marang pendapatan KTRA|Multiplikator P/S Oncternal Corp|Kapitalisasi marang pendapatan PRTG (Portage Biotech Inc.)